Simulation and Matching-Based Approaches for Indirect Comparison of Treatments

Estimates of the relative effects of competing treatments are rarely available from head-to-head trials. These effects must therefore be derived from indirect comparisons of results from different studies. The feasibility of comparisons relies on the network linking treatments through common comparators; the reliability of these may also be impacted when the studies are heterogeneous or when multiple intermediate comparisons are needed to link two specific treatments of interest. Simulated treatment comparison and matching-adjusted indirect comparison have been developed to address these challenges. These focus on comparisons of outcomes for two specific treatments of interest by using patient-level data for one treatment (the index) and published results for the other treatment (the comparator) from compatible studies, taking into account possible confounding due to population differences. This paper provides an overview of how and when these approaches can be used as an alternative or to complement standard MTC approaches.

[1]  V. Hasselblad,et al.  Meta-analysis of Multitreatment Studies , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[2]  R. Oaxaca Male-Female Wage Differentials in Urban Labor Markets , 1973 .

[3]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[4]  Douglas G Altman,et al.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.

[5]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[6]  Alex J. Sutton,et al.  Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .

[7]  D. Alemayehu Assessing exchangeability in indirect and mixed treatment comparisons , 2011 .

[8]  Noemi Kreif,et al.  Overview of Parametric Survival Analysis for Health-Economic Applications , 2013, PharmacoEconomics.

[9]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[10]  Ronald L. Oaxaca,et al.  On discrimination and the decomposition of wage differentials , 1994 .

[11]  W. Henley,et al.  Improved curve fits to summary survival data: application to economic evaluation of health technologies , 2011, BMC Medical Research Methodology.

[12]  G. Lu,et al.  Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .

[13]  Mei Lu,et al.  Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  A. Blinder Wage Discrimination: Reduced Form and Structural Estimates , 1973 .

[15]  Julian P T Higgins,et al.  Recent developments in meta‐analysis , 2008, Statistics in medicine.

[16]  Alan Brennan,et al.  Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis , 2007, Statistics in Medicine.

[17]  R. Fairlie An Extension of the Blinder-Oaxaca Decomposition Technique to Logit and Probit Models , 2006, SSRN Electronic Journal.

[18]  Theo Stijnen,et al.  Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.

[19]  K. Jack Ishak,et al.  No Head-to-Head Trial? Simulate the Missing Arms , 2012, PharmacoEconomics.

[20]  Eric Q. Wu,et al.  Comparative Effectiveness Without Head-to-Head Trials , 2012, PharmacoEconomics.

[21]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[22]  T. Lumley Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.

[23]  Nicky J Welton,et al.  NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .